US Broker Ratings

Eli Lilly and Company (LLY)

⚠️ No article content returned.

..

DaVita Inc. (DVA) Stock Analysis: Uncovering a 19.58% Upside Within the Healthcare Sector

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector specializing in kidney dialysis services, is attracting attention from investors with its substantial potential upside and strong performance metrics...

DexCom, Inc. (DXCM) Stock Analysis: Strong Buy Ratings and Promising Growth in the Medical Device Sector

DexCom, Inc. (NASDAQ: DXCM), a prominent player in the healthcare sector, is making waves in the medical devices industry with its cutting-edge continuous glucose monitoring (CGM) systems. As investors look..

HealthEquity, Inc. (HQY) Stock Analysis: Unpacking a 25% Upside Potential in the Healthcare Sector

Investors have their sights set on HealthEquity, Inc. (NASDAQ: HQY) as it continues to demonstrate its stronghold within the healthcare technology sector. With a market capitalization of $7.87 billion, HealthEquity..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a 36.73% Potential Upside

AptarGroup, Inc. (NYSE: ATR), a key player in the healthcare sector’s medical instruments and supplies industry, offers investors a unique opportunity for growth with a notable 36.73% potential upside. Headquartered..

Bio-Techne Corp (TECH) Investor Outlook: Navigating Market Dynamics with a Focus on Growth Potential

Bio-Techne Corp (NASDAQ: TECH), a prominent player in the biotechnology sector, presents a unique investment opportunity in the ever-evolving healthcare landscape. With a robust market capitalization of $11.35 billion, Bio-Techne..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Powerhouse with 11.97% Potential Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is a prominent name in the biotechnology sector, known for its groundbreaking work in treating serious diseases like cystic fibrosis (CF) and sickle cell disease..

Charles River Laboratories (CRL) Stock Analysis: A Healthcare Giant with a Modest Upside

Charles River Laboratories International, Inc. (NYSE: CRL) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $13.27 billion, the..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Analyzing a 20% Potential Upside Amid Biotech Innovation

Roivant Sciences Ltd. (NASDAQ: ROIV), with a market capitalization of $28.73 billion, stands as a notable player in the healthcare sector, specializing in biotechnology. This UK-based biopharmaceutical company has carved..

West Pharmaceutical Services (WST) Stock Analysis: A Healthcare Powerhouse with 11.89% Potential Upside

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a robust market capitalization of $25.5..

Zimmer Biomet Holdings, Inc. (ZBH) Investor Outlook: Strong Potential Upside with 12.81% Amid Robust Product Portfolio

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a leading player in the healthcare sector specializing in medical devices, has caught the attention of investors with its promising growth potential and robust..

Haleon plc (HLN) Stock Analysis: A 29% Potential Upside in the Healthcare Sector

Haleon plc (HLN) is carving out a significant presence in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $40.81 billion, this..

Agilent Technologies, Inc. (A) Stock Analysis: Unveiling a 11.81% Potential Upside in Diagnostics & Research

Agilent Technologies, Inc. (NYSE: A), a leader in the healthcare sector’s diagnostics and research industry, offers a compelling investment case for those seeking robust growth opportunities. With a market capitalization..

Penumbra, Inc. (PEN) Stock Analysis: Evaluating a 13.93% Upside Potential

Penumbra, Inc. (NYSE: PEN), a key player in the medical devices sector, has garnered attention from investors with its innovative healthcare solutions and promising market position. Based in Alameda, California,..

Chemed Corp (CHE) Stock Analysis: Exploring 9.51% Potential Upside and Strong Return on Equity

Chemed Corp (NYSE: CHE), a notable player in the healthcare sector specializing in medical care facilities, stands out with a market capitalization of $6.59 billion. The company is integral to..

Merck & Company, Inc. (MRK) Growth Potential: Analyzing Analyst Ratings and Strategic Collaborations

Merck & Company, Inc. (NYSE: MRK) is a titan in the healthcare sector, specifically within the drug manufacturing industry. With a formidable market capitalization of $362.35 billion, Merck is a..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a -22.39% Potential Downside Amidst Biotech Innovation

For investors eyeing the biotechnology sector, Moderna, Inc. (NASDAQ: MRNA) presents a fascinating case study of both potential and risk. With a market capitalization of $61.5 billion, this Cambridge, Massachusetts-based..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Exploring a Promising 43% Potential Upside

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) stands out in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $14.86 billion, this San Diego-based..

Labcorp Holdings Inc. (LH) Stock Analysis: Unveiling a 7.34% Potential Upside Amidst Strong Buy Ratings

Labcorp Holdings Inc. (NYSE: LH), a prominent player in the healthcare sector, is capturing investor attention with its robust market presence and strategic expansions. As a leader in the Diagnostics..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Unveiling a 19% Upside Potential in the Healthcare Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN), a prominent player in the healthcare sector specializing in medical devices, is capturing attention with its notable potential upside of 19.33%. Headquartered in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds